0000950103-21-008458.txt : 20210604
0000950103-21-008458.hdr.sgml : 20210604
20210604185212
ACCESSION NUMBER: 0000950103-21-008458
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210602
FILED AS OF DATE: 20210604
DATE AS OF CHANGE: 20210604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Urist Marshall
CENTRAL INDEX KEY: 0001838139
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39329
FILM NUMBER: 21997813
MAIL ADDRESS:
STREET 1: C/O ROYALTY PHARMA PLC
STREET 2: 110 EAST 59TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Royalty Pharma plc
CENTRAL INDEX KEY: 0001802768
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 110 EAST 59TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 883-0200
MAIL ADDRESS:
STREET 1: 110 EAST 59TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
dp152317_4-urist.xml
FORM 4
X0306
4
2021-06-02
0
0001802768
Royalty Pharma plc
RPRX
0001838139
Urist Marshall
C/O ROYALTY PHARMA PLC
110 EAST 59TH STREET
NEW YORK
NY
10022
0
1
0
0
EVP & Co-Head Research & Inv.
Class A Ordinary Shares
2021-06-02
4
S
0
14566
41.5248
D
33134
D
Class A Ordinary Shares
19020
I
By IRA
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.18 to $41.86 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
All reported transactions were effected pursuant to a 10b5-1 plan adopted by the reporting person on March 29, 2021.
/s/ Jason Mehar, as Attorney-in-Fact for Marshall Urist
2021-06-04